Table 2 Clinical and demographic data of the studied patients (1,079 patients)

Age, years

11.4 ± 3.9

Ethnicity, n (%)

Caucasian

566 (52.5%)

Non-Caucasian*

513 (47.5%)

Gender, Female n (%)

573 (53.1%)

Age at diagnosis, years

6.9 ± 3.9

Age at diagnosis, years n (%)

0-4.9

353 (32.7%)

5-9.9

412 (38.2%)

10-14.9

282 (26.1%)

15 or more

32 (3.0%)

HbA1c (%)

9.2 ± 2.3%

Duration of diabetes, years

4.5 ± 3.5

Levels of care, n (%)

Secondary

373 (34.6%)

Tertiary

706 (65.4%)

Medical follow-up at the participating center,y

3.6 ± 3.0

Diabetes treatment, n (%)

Insulin

Intermediate or long-acting

170 (15.8%)

Intermediate or long-acting plus short acting

904 (83.8%)

Insulin Pump

5 (0.4%)

Long-acting shots ≥ 3/day, n (%)

439 (40.7%)

Short-acting shots ≥ 3 /day, n (%)

591 (54.8%)

SMBG, n (%)

1,015 (94.1%)

SMBG/day

3.4 ± 1.6

Hypoglycemia, n (%)

610 (56.5%)

Hospitalization, n (%) **

190 (17.9%)

Clinical visits last year

4.3 ± 1.7